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We describe a patient with severe generalized dys-
trophic epidermolysis bullosa (EBD) and a novel 
combination of compound heterozygous mutations 
in the COL7A1 gene. The maternal mutation was an 
A-to-G transition (425-A ---7 G) at position -2 of the 
donor splice site within exon 3 that causes aberrant 
splicing of two abnormal transcripts. One includes 
intron 3, and one excludes both exon 3 and intron 3. 
Both splice variants contained a premature termina-
tion of the translation. The paternal mutation is a 
25-bp deletion in exon 20 (2638del25) that leads to a 
frameshift and a premature termination codon 133 bp 
downstream from the site of deletion. This combina-
tion of mutations allowed expression of collagen VII 
mRNA. Immunofluorescence staining of the patient's 
skin and cultured keratinocytes with domain-specific 
Epidermolysis bullosa dystrophica (EBD) is a h eteroge-neous group of heritable skin disorders with trauma-induced blistering and scarring of the skin and the mucosal ~urfaces of the respiratory and gastrointestinal tracts (Fme et a/, 1991; Bruckner-Tuderman, 1993; 
Gedde-Dahl and Anton-Lamprecht, 1996). The clinical h eteroge-
neity is reflected by biologic alterations, such as absent or abnormal 
anchoring fibrils (Gedde-Dahl and Anton-Lamprecht, 1996) and 
absent or attenuated expression of collagen VII (Heagerty et a/, 
1986; Bruckner-Tudennan et a/, 1988, 1992; Konig et a/ , 1994a, 
1994b), the major structural protein of the an choring fibrils in the 
skin (Burgeson, 1993; M.arinlwvich, 1993), as a result of a spectrum 
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collagen VII antibodies, however, detnonstrated mark-
edly reduced levels of al(VII) polypeptides, and no 
stable collagen VII protein could be extracted from 
the patient's cells. Electron microscopy showed se-
verely hypoplastic fibrils below the lamina densa, 
without evidence of normal anchoring fibrils. The 
clinically unaffected parents were heterozygous for 
the mutations, suggesting that both COL7A1 gene 
defects were recessively inherited disease-causing 
mutations that are "silent" in heterozygous carriers 
but in combination can severely interfere with the 
dermal-epidermal adhesion and lead to severe EBD. 
Key WOJ'ds: auclwringji.bJ'ilslbasem.eut mem.bra.ne/bullo11s dis-
eases/recessive dystJ'ophic epidermolysis bullosa. J I1west Det'-
matol 109:384-389, 1997 
of different mutations m the collagen Vll gene COL7 Al (for 
review, see C hristiano and Uitto , l996a, 1996b). 
Patients with recessive EBD are frequently compound heterozy-
go us for two mutations, except for probands fi·om consanguineous 
marriages (Chdstiano and Uitto, 1996a, 1996b). Mutations leading 
to premature termination codon s (PTC) on both alleles ofCOL7 Al 
seem to underlie the most severe cases, whereas a combination of 
a PTC with a missense mutation yields a milder phenotype (Dminill 
ct a/, 1996; Shimizu et a/, 1996). fnterestingly, homozygosity or 
compound hete rozygosity for two missense mutations has been 
reported in the literature on ly iil few cases (Christiano et a/, 1993 ; 
Gardella ef a/, 1996; Winberg cl a/, in press). Most of the sequence 
variations repor ted th us fa r represent nove l mutations; i.e ., every 
EBD family has different gene defects. Identical muta tions have 
been described in different families on ly a few times (Bruckner-
Tuderman et al, 1995; Christiano et a/, 1995; Gardella el a/, 1996; 
Winberg et a/ , 1996). ln spite of the fac t that many COL7A1 
mutation s have recently been disclosed , th e genotype-phenotype 
correlations in EBD are only beginning to emerge . The biolog ic 
consequences of the genetic constellations and th eir effects on the 
synthesis of coHagen Vll polypeptides and polymerization of th e 
anchoring fibril s have r emained largely elu sive, and investigations 
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of more affected families a re required for understanding the d etaile d 
pathogen etic m echanisms underlying EBD. 
In thi s study, we attempted an alysis of the genotype-phenotype 
correla tio n in a patient with severe recessive EBD. The proband 
was compound h eterozygous for two COL7 Al mutations; one of 
which was a splice-site mutation that resulted in synth esis of 
truncate d mRNA transcripts, and the other was a d eletion that led 
to a frameshift and a PTC downstream. We show that these genetic 
alte rations lead to the absence of intact collagen VII and functional 
ultrastructurally nor m al anchoring fibrils in the skin of the patient 
and , therefore, caused the severe EBD phenotype. 
MATERIALS AND METHODS 
Patient The proband, a male hom in 1992, was the first child of healthy 
nonconsa.nguineous pat·ents . T here was no fa mily history of related skin 
diseases o r similar genetic disorders. At birth , a localized skin defect was 
observed on the back of the left hand, and subsequentl y, multiple blisters 
developed over the trnnk and the extremities . The skin remained fragile , 
and minor friction caused blisterin g. Mechanically exposed sites (e.g., 
hands, feet, elbows, knees, inner thighs , neck, and also the oral mucosa) 
remained continuo usly affected. The blisters healed wi th erythematous 
scarring and milia . All nails were lost by the age of 1 y, and by the age of 4 y 
contractu res of the fingers developed, without significant webbing. Severe 
involvement of the eyes was problematic, with continuo us blistering 
causing pain and sensitivity to light . T hus, the patient presented with a 
phenotype of severe generalized EDD. 
Mutation Detection Mutations were detected by using heteroduplex 
analysis of polymerase cha in reaction (PCR) products amplified from 
genomic DNA or eDNA. Genomic DNA was isolated from peripheral 
blood by using the Easy-D N A kit according to the manufacturer's instruc-
tions (Invitrogen, Leek, The N etl1erlands) . A mplification o f exons 3 and 20 
of COL7A1 was ca rried out with primers placed on the flanking intronic 
sequences. Primers used for amplification of exon 3 (nucleotide positions 
267-426 in the eDNA; GenBauk accession no. L02870) were sense primer, 
5'-GGCCAGAAGAGATCCTGAGT-3 ', and anti- sense p rimer, 5'-CT-
GACCTGTCACTCCTGCTC-3'. T he size of the PCR prod uct was 422 
bp . Primers used fo r amplification of exon 20 (nucleotide positions 2588 -
2710 in the eDNA; GenBank accession no. L02870) were sense primer, 
5' -CTCCCTGATTCCTGAGCTTT-3 ', and anti-sense primer, 5'-GGAG-
GAGTCACTCAGAGTCG-3'. T he size of the ampli fica tion product was 
709 bp. For PCK, 100 ng of genomic D N A was used as template, and 
amplification conditions were 95°C fo r 2 min , fo llowed by 40 cycles of 
95°C for 45 s, 60aC for 45 s, and 72aC for 45 s in an Perkin-Elmer 9600 
thermal cycler (Perkin-Elmer Cetus, Uberlingen, Germany). The amplifi-
cation reac tion contained lO X PCR buffer (GffiCO/ BRL, Eggenstein, 
Germany), 1 unit of Tnq polymerase (GIBCO/BRL), aU four deoxynucle-
otide triphosphates (each at 0. 2 mM), and 1 J.LM primers, in a total volume 
of 50 J.LI. PCR products (5 J.Ll) were analyzed by agarose gel electwphoresis 
on l.S% gels. 
To study the consequences of the mutations detected in genomic DNA, 
reverse tra nsniption-coupled (KT-PCR) was used to ampli fy the mutated 
regions. Kerati.nocyte mRNA was isolated by using the QuickPrep Micro 
mR.NA purification kit (Pharmacia Biotech, Freiburg, Germany), and 
eDNA was synthesized by using the First Strand Synthesis For RT-PCR kit 
(Amersham, Buckinghamshire, England) according to the manufacturer's 
instructions. Primers used for am plification of the eDNA corresponding to 
nucleotide positions 193-542 (GenBank accession no. L02870) were sense 
primer, 5'-GTGCTGCCTTTCTCTGGA-3' , and anti- sense primer, 5'-
TCAGGGTCAGCATTCTTG-3'. The size of the PCR product was 349 
bp . For amplification, 100 ng of eDNA was used as template, and 
amplifica tion conditions were 95°C for 2 min, followed by 40 cycles of 
95°C for 45 s, 57°C for 45 s, and 72°C for 45 s in an Perkin-Elmer 9600 
thermal cycler (Perkin-Elmer Cetus). Primers used for amplification of the 
eDNA corresponding to nucleotide positions 2492-3009 (GenBank Acces-
sion no. L02870) were sense primer, 5'-TCCGGGGTCTCGAAGGTGGA-
3', and anti-sense primer, 5'-CGGGGACCCAGGCACTTCC-3'. T he size 
of the PCR product was 517 bp. The ampli fication conditions were 38 
cycles of 95°C for 60 s, 63°C for 60 s, and 72°C for 60 s. 
H eteroduplex analyses were performed with conformation-sensitive gel 
electrophoresis (Ganguly et a/, 1993). For the analysis, the PCR products 
were denatured fo r 5 min at 95°C, fo llowed by cooling down to 35°C over 
1 h and electrophoresed overnight at 500 V. After electrophoresis , the gel 
was stained in SYBR Green (] (FMC BioProducts, Rockland, ME) diluted 
1:10,000 in Tris/borate/EDTA electrophores is buffer or in e tltidium bro-
nude for 20 min with gentle agitation . The gel was transferred to a UV 
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illwninator and photographed. If a heteroduplex was detected, the PCK 
products were sequenced w ith an auto mated sequencer (Applied Biosys-
tems, Foster City, CA). ln some cases, the PCR products were subcloned by 
T I A cloning kit (Invitrogen , Leek, The Netherlands) , followed by auto-
mated or manual sequencing (Sequenase sequencing kit, USB, C leveland, 
OH). 
Verification of the Mutations The maternal mutation, 425- A---> G was 
verified by Styl restriction enzyme digestion. T he enzyme cleaved the 
normal 422-bp PCR product with tl1e base Gat position 425 to two 211 -bp 
fragments. T he PCR products with the base A at position 425 remained 
undigested. T he paternal mutation, 2638del25 was verified by Bm11HI 
restriction enzyme digestion. The restriction enzyme cleaved th e normal 
709-bp PCR product into two fragments of 449 bp and 260 bp . T he 25-bp 
deletion led to a clearly detected tlurd band of 235 bp. T he restriction 
enzymes were from Boehringer Mannheim (Mannheim, Germany) and tl1e 
reactions ·were carried out according to the tnanufacturer's instructions. 
Northern Blotting Poly(A) + RNA was isolated from cultured keratino-
cytes w ith Phannacia QuickPrep mKNA purification Kit (Pharmacia LKB 
Biotechnology, Di.ib endorf, Switzerland). For northern blotting, 1-3 J.Lg of 
kera tinocyte mRNA was sepa.rated on a 1% agarose gel contaitling 2.2 M 
forma ldehyde, vacuum-transferred onto a Nytran nylon ftlter (Schleicher & 
Schuell , Dassel , German y), and immobilized with UV-linking (Stratalinker, 
Stratagene, Heidelbe rg, Germany). T he filters were pre-hybridized and 
hybridized (Sambrook el nl, 1990) wi tl1 radiolabeled collagen VII eDNA 
K13 1 (Christiano ct a/, 1994). A eDNA of the GAPDH gene was used as a 
reference pro be to correct for minor differences in RNA loading. After 
hybridi zation the fi lters were washed to a fmal stringency of 0.1 X standard 
saline citrate/0.5% sodium dodecyl sulfate (SDS) at 65 °C . T he radioactive 
cDNA-mRNA hybrids were visualized by au toradiography by exposure of 
the filters to x-ray fi lms (X-Omat, Eastman Kodak, Rochester, NY) . 
Skin Biopsies and Cell Cultures Biopsies were obtained from clitlically 
unaffected , perilesional, and lesional skin for antigen mapping, electron 
microscopy, and cell cul ture. Keratinocytes of w1affected skin were obtained 
by trypsinization of control and EBD biopsies and cnltured in semm- free 
keratinocyte growth m edium (GIBCO Life T echnologies, Eggenstein, 
Germany) as described eadier (Konig ct a/, 1994a, 1994b) . Fibroblasts were 
initiated from control and .EBD skin with the exphmt culture method and 
cultivated by using routine techniques. 
Immunofluorescence (IF) and Immunoblottiug Antigen mapping of 
the skin biopsies was carried o ut with antibodies against collagens IV, VII, 
and XVTI , lam inin 5, a6{34 integrin, BP230, and cytokeratins, as described 
previously (Bruckner-T uderman 1993). Domain-specific affinity-purified 
antibodies against the triple-helical and tl1e NC- 2 domau1 of human 
collagen VII were prepared as described earlier (Konig and Bruckner-
T uderman, 1992; Bruckner-T uderman et a/ 1995). The monoclonal <mti-
body LH-7.2 (Leigh eta/ , 1987) against theN- terminal globular domain of 
collagen VII was a kind gift fro m Dr. I. Leigh, T he London Hospita l, 
London, U .K. IF staining of cultured cells was carried out by standard 
m ethods. For extraction of collagen Vll , normal and EBD keratinocytes 
were treated with a chao tropic buffer containing urea and SDS. The samples 
were separated by SDS-polyacrylantide gel electrophoresis under reducing 
conditions, with a 4.5-15 '!/o polyacrylamide gradient and immunoblotted 
with collagen VII an tibodies overnight (Kotlig et a/, 1994a) . 
Electron Microscopy The biopsy sample, ob tained at tl1e age of 10 d, 
included lesional and intact perilesional skin. It was prepared for tran smis-
sion electron nucroscopy as described elsewhere (Anton-Lamprecht, 1992). 
l11 brief, fixation with 3% glutardialdehyde in 0.1 M cacodylate buffer 
solu tio n (pH 7 .4), partially oxidized by addition of H 20 2 , post-fixation in 
osmic acid in the same buifer, dehydration, and final embedding in epo"")' 
resu1 . Semithin sections were stained w ith methylene blue, and ultrathin 
sections were treated with uranyl acetate and lead citrate. Electron micro-
scopic uwestigations were performed witl1 a Philips EM 400 at 80 kV 
accelaratio n voltage. 
RESULTS 
C01npouud Heterozygosity for COL7A1 Mutations 
The N!atem.al Splice S ite Mutat io11. Conformation- sensitive gel elec-
trophoresis analysis of genomic PCR products sparming exon 3 
reveale d three h eteroduplex bands it; th e patient's and his mother's 
DNA, w h e reas homoduplex b ands were fo und i11 the £,tber's and 
unrelated controls (Fig 1A). This el ectrophoretic pattern su ggested 
h e terozygosity of the mother and the patient for the sam e nucleo-
tide change, and direct seque n cin g of th e PCR products confirm ed 
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Figure 1. Maternal splice site mutation- (A) H eteroduplex analysis of 
the PCR product of genomic DNA containing exon 3 revealed two 
heteroduplex bands in the patient's DNA (ln11e 4) and his mother's DNA 
(/nne 2), but not in the f.1ther's DNA (ln11e 3) and the normal control DNA 
(/n11e 1). (B) Automated sequence analysis of the patient's DNA showed a 
heterozygous A-to-G transition at nucleotide position 425 of the eDNA, at 
position -2 of the donor splice site of intron 3. (C) T he mutation was 
verified by the loss of a Styl restriction enzyme site. The 422-bp PCR. 
products of a control (ln11e 4) and the f.1ther (la11e 1) were digested to two 
equal fragme nts of211 bp. The heterozygous patient (ln11e 3) and his mother 
(la11e 2) showed an additional uncleaved band of 422 bp. 
this assumption. Both probands were heterozygou s for A-to-G 
transition at position 425 of the eD NA within exon 3, d esignated as 
425-A ~ G (Fig 1B), at position -2 of the donor splice site. This 
Figure 2. Analysis of aberrant splici.ng. 
(A) RT-PCR ampli6cation of mRNA with 
primers covering exons 2-4 produced an 
ampl.imer of349 bp in a normal control (ln11c 
1). The ampli6 cation of the patient's mR.NA 
resulted in three ampl.imers. of 436 bp, 349 
bp, and 189 bp (lmtes 2, 3). The two add i-
tional bands (marked with an *) represent 
the 436- and 189-bp products with altered 
mobili ty due to different secondary struc-
tures. Lnw~ !vi contclins n1olccular size nlark-
crs. (B) Subcloning and sequencing of the 
patient's PCR.-products demonstrated that 
the 349-bp fragment represented the normal 
splice product. The 436-bp fragment con-
tained, in addition to the normal sequence, 
intron 3. The 189-bp PCR. product excluded 
exon 3. (C) Allele-specific Styl restriction 
enzyme analysis of a normal control showed 
a complete digcstiou of the 349-bp amplimcr 
to fiagmcnts of 230 bp and 119 bp (laiw 2) . 
The patient's abnormal PCrt ampl.imers of 
436 bp and 189 bp (lane 3) remained undi-
gested (lane 4) , whereas the patient's normal 
amplimer was complete ly digested (lane 4). 
The samples were the normal PCR. product 
before (lane 1) and after (lan e 2) digestion and 
the patient's PCR products before (lane 3) 
and after (ln11e 4) Styl digestion. La11e M 
contains molecular size markers. (D) In 
northern blot analysis, mR.NA of the pa-
tient's keratinocytes (lane 1) and of normal 
contro ls {la11e 2) were hybridized with a 
collagen VII eDNA (nppet). Doth ce lls con-
ta ined the normal 9-kb COL7Al mRNA. 
To correct for small differences in loading of 
the mRNA, hybridization with a eDNA 
from the GAPDH gene, a housekeeping 
gene was carried out (lower). 
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sequence variation was verified by Styi restt;ction enzyme digestion 
of the 422- bp PCR product. The restt;ctiou enzyme diges tion 
resu lted in two equal fragments of211 bp (Fig 1C). This mutation, 
was first described by Christiano et nl (1994) who suggested it as a 
neutral Lys-to-Arg polymorphism, but recently Gardella et nl (1996) 
showed it to be a disease-causing splice-site mutation . Therefore, 
RT-PCR analysis of the COL7A1 mRNA of th e patient was 
undertaken (Fig 2) . RT-PCR with primers placed on exons 2-4 
resulted in three PCR products, 436 bp , 349 bp, and 189 bp , 
Sllggesting aberrant splicing products (Fig 2A). Subcloning and 
sequencing of the PCR products disclosed a normal and two 
abnormal mRNA splice products. Of the abnormal products, one 
(436 bp) included the 87- bp intron 3 and the other (189 bp) 
excluded both exon 3 and intron 3. Both abnormal splice variants 
contained a PTC, the first one at the 66th nucleotide of intron 3, 
and the second at the 10th nucleotide of exon 4 (Fig 2B) . The 
maternal 425- A ~ G transition eliminated a Styl restriction enzyme 
cleavage site. Therefore, tlus restric tion enzyme was used to 
identify the origin of the RT-PCR products (alle le-specific analy-
sis). Styl digestion of the 349-bp amplimer fi:om a normal control 
resulted in two fragments of230 bp and 119 bp . ln the patient, the 
normal amplimer was completely cleaved . In contrast, both abnor-
mal transc1;pts , 436 bp and 189 bp, remained undigested (Fig 2C) . 
This indicated that the matemal allele only produced alternatively 
spliced transcripts, whereas the normal spli ce product was tran-
scribed fi·om the paternal allele. 
On the agarose gel of the R.T-PCR produ c ts shown in Fig 2A, 
two additional bands were observed (marked with *). Subclon.ing 
of the bands always resulted in clones containing the 436-bp or 
189-bp products, and polya crylamide gel electrophoresis after 
denaturation of the samples revealed that th ese additional bands 
8 349 bp 
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Figure 3 . Patern a l deletion mut a t ion. (A) H cteroduplcx analys is of ti ll! 
PC R prod uct of geno mic DNA conta ining exo11 20 revealed fo ur bands i11 
the patiem's D N A (ln11e 3) and his fathe r's D N A (ln11e 4). O ne showed 
migration similar to normal controls (/ewe ·t), and three m igrated dilferendy. 
T he mother's DNA showed a homoduplex band o nly (ln11e 2), sim ilar to 
COil tro ls. (B) Subclon i11 g and m anual sequencing of the patien t's PC R 
product showed a heterozygous 25-bp deletion at nucleotide positions 
2638-2663 o f the cON A. (C) To veri fy the 25-bp de letion in th e geno m ic 
DNA of the f.1rher, the PCR prod ucts of geno mic DNA spanning exon 20 
(709 bp) were cleaved with BnmH l restriction enzyme. T he digestion 
resul ted in two fragm en ts of 449 bp and 260 bp co rresponding to the norma l 
all ele . In the samples from the patient (ln11 e 3) and the father (ln11e 4), but not 
from the mod1er (ln11 e 2) o r the a contro l (la11e 1), the 25-bp deletion led to 
a clea rly de tected third band of235 bp (~). (D) Agarose gel electropho resis 
of RT-PC R produ cts w ith p rimers span ning ex o n 20 showed one band of 
517 bp in the contro ls (laue 1). In d1e patien t's sample (la11c 2), two bands 
were obse rved (~). o ne of th e expected size and the other slightly smaller, 
indicatin g the presence of two mRNAs. 
represented the 436- and 1 89-bp products with alte red m obili ty due 
to cli frerent secondary structures (da ta n o t shown). 
N orthern blotting showed a strong COL7 A 1 mKNA signal in 
contro l and patient kera tinocytes (Fig 2D). 
T he A- to- G substitu tion was not found in 150 alleles of unre lated 
unaflected individu als and in 38 chromosom es of unrelated EBD 
pa tients by Styl digestion , indica ting that it is not a common neutral 
polym orphism . T hi s fi nding was also consistent w ith the fact that 
hete rod up lex analysis and /or sequencing of the en tire coding 
region of COL7 A1 revealed no other mutati ons in th e prob and. 
T he Paternal Frn111 eslt ift M utaticm Heteroduplex analysis of PCK-
amplified genomic DNA encoding exon 20 revealed four bands 
(Fig 3A). Subcloning and sequencing of the PCK produ cts revea led 
a heterozygous 25-bp deletion in the patient's (Fig 3B) and his 
f.1ther 's D N A (data no t shown) at nucleotide position 2638 - 2663 of 
the eDN A. T he m uta tion , designa ted as 2638del25, caused a 
fra meshift and a PTC 133 bp downstream from the si te of deletion . 
For veri fica ti on of th e deletion, restriction en zym e digestion w ith 
Bm11HI was used, which cleaved the 709-bp PCR product to two 
fi·agments of 449 bp and 260 bp . For the heterozygous de letion, a 
clearly de tected third band of 235 bp appeared (Fig 3C). After 
electrophoresis in a 2% agarose gel, the K T -PCK produ cts of the 
patient showed an addition al band with faster mobility (Fig 3D). 
Low Levels of Immunoreactive Collagen VII in the Skin 
and Cutaneous Cells IF staining of the patient's skin with 
antibodies against the amino-terminal N C-1 dom ain of collagen 
VII revealed a very faint flu orescence at the basem ent mem brane 
zone, indica ting m ar kedly reduced production of collagen V rr (Fig 
4B) . Antigen m apping with antibodies against other components of 
the dermo- epidermal junction (DEJ) (i .e., collagens IV and XVII, 
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laminin 5, BP230, and cytokeratins) showed normal staining that 
loca lized to the blister roof in separated areas (Fig 4C) . T h is pattern 
confixmed the di agnosis ofEBD and attested to the specific ity of the 
alte red coll agen V H IF. 
Domain-specifi c collagen VII antibodies were used for IF stain -
in g of cul tured keratinocytes. Staining with antibodies to the NC- 1 
domain, the triple-helical domain , or the NC-2 domain resul ted in 
a positive in tracellular granulax IF in control keratinocytes (Fig 
4D) . In contrast, a very fa in t staining with the an tibodies to the 
N C - 1 domain was observed in the patien t's keratinocytes (Fig 4E), 
and the staining was negative with the other an tibodies against 
collagen VU. T his o bservation suggested synthesis of trun cated 
collagen VII polypeptides in kera tin o ytes as predicted by the 
m utations characterized in this study. 
To stud y the nature of the immw1oreactive material observed by 
l f staining, confl uent keratinocytes were extracted and imm un ob-
lotted w ith antibodies against collagen VII. A single band of about 
300 k.Da representing th e al(Vll) polypeptide chains was observed 
in control extracts, but no ba nds were detected in EBD extracts 
(Fig 5). T his suggested that the truncated polypeptides synthesized 
in the cells were labil e and did not resist the ex traction procedures. 
Figure 4 . Inun unodete c t ion o f collagen VII. TF staining of a contro l 
and EBD skin and keratinocytes with an an tibody against the N -1 dom ain 
of collagen V II. (A) Contro l skin showed a linear IF at the DEJ. (B) T he 
pati ent\ skin dem onstrated spon taneous blistering and exhibited a barely 
visib le stain ing at the bLi ster roof. T be 0 indicate the bLister base. (C) 
Staining of the patien t' s skin with an tibodies to lam inin 5 showed a positive 
IF of the basement membrane at the blister roof. T he 0 ind icate the blister 
base. (D) Normal keratinocytes exhibited a g>·anu lar intrace llu lar staining 
with the antibody to the NC- 1 do main of co llagen V II. (E) T he patient's 
kcratinocytes showed ortl y fai nt immunoreactivity. (F) Negative con trol 
w ithout the first an tibody. 
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Figure 5. lntmunoblot analysis. Collagen VII was extracted with 
chaotropic agents from normal and EBD keratinocytes, separated on an 
SDS-polyacrylamide gel electrophoresis with a 4.5-lS'X, polyacrylamide 
gradient, and immunoblotted with antibodies to the NC-1 domain of 
collagen VII. Lmw 1, Control kera.tinocytc extract; la11e 2, control dermis 
extract; la11es 3 and 4, EBD keratinocyte extract . No collagen Vll was 
detected in the EBD extracts. 
Ultrastructure of the Anchoring Fibrils The skin sample for 
electron microscopy included lesional and uninvolved skin with 
long unsplit areas ofDEJ. Fresh splits due to biopsy trauma showed 
detachment of the epidermis immediately underneath the basal 
lamina, exactly in the plane of the anchoring fibrils. The larnina 
den sa formed the undersurface of the blister roof, confirming the 
cli.nical suspicion of dystrophic EB. 
In the intact areas of DE], no normal anchoring fibrils w ere 
demonstrable. Only occasionally very thin and short fibrils were 
revealed (Fig 6), lacking a banding pattern but inserting into basal 
lamina thus presumably representing severely hypoplastic fibt;ls . 
Most otl1er areas of the DEJ were totally devoid of anchoring fibrils . 
Tbis pronounced degree of hypoplasia coJTesponded to that of 
many other cases of severe generalized mutilating or submutilating 
recessive dystrop hic EB. Thus tlus diagnosis was stated shortly after 
birth based on the ultrastructure of the anchoring fibrils, pointing to 
the severe risk and possible mutilation tendency. 
DISCUSSION 
The proband examined in this study was compound heterozygous 
for a novel combination of COL7A1 mutations, a maternal point 
mutation 425-A ---7 G, and a paternal deletion 2638del25. The 
paternal deletion is a novel mutation that caused a frameshift and a 
PTC. The matemalmutation is identical to that described recently 
by Gardella et nl (1996) in an Italian fumily. It caused aberrant 
splicing variants of COL7A1 mRNA. RT-PCR with primers 
placed within exons 2-4 produced three amplification products. 
DNA sequencing of the products demonstrated that one corre-
sponded to the norn1al transcript, the other contained insertion of 
the 87-bp intron 3, and the third had deletion of the 160-bp exon 
Figure 6. Electron microscopy. (a) 
DEJ of neonatal skin of the EBD patient with 
very thin, short, and faint fibrils inserting in 
the basal lamina (-->) that represent severely 
hypoplastic anchoring fibrils; the split oc-
curred in this plane of the junction (data not 
shown). (b) DEJ with anchoring fibrils of 
normal length and ultrastructure (-->) but 
defective hemidesmosomes (0) in neonatal 
skin of jtmctional EB Hertlitz. Swlc bnrs, 0.5 
J.Llll (fi1nl magnification, X 43 ,000). 
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3. Both abnormal variants resulted in a PTC. Both of these splice 
variants were also observed by Gardella et nl (1996), in addition to 
a third variant initiating from a cryptic splice site within intmn 3. In 
our proband, the tlurd abnm:mal splice variant was not present. 
Because PTC have in many instances been shown to cause 
non-sense-mediated mRNA decay (Maquat et nl, 1995), it was 
unexpected that northem blotting revealed a strong collagen VII 
mRNA signal in the patient's samples. Allele-specific analysis 
demonstrated that for the maternal425-A ---'> G mutation, RT-PCR 
products with normal size originated from the paternal allele and 
that the two bands with abnormal size corresponded to the 
maternal allele, but it remains unclear whether both alleles, or only 
one of them, contributed to the full-size mRNA observed in 
northern blots. 
In spite of the expression of COL7A1 mRNA in the patient's 
cells, no intact collagen VU polypeptides were fow1d in the 
keratinocyte extracts by U11111UJ1oblotting, and only a weakly posi-
tive IF signal with antibodies to theN terminus of the molecule was 
noted with cuJtured keratinocytes . In contrast, in the skiJl the 
fluorescence was barely visible at the basement membrane zone. 
The paternal mutation in exon 20 resulted in synthesis of a 
polypeptide with 916 amu1o acids correspondu1g to the NC-1 
domain sequence with additonal 44 amino acids with a missense 
sequence. The truncated polypeptides are predicted to have a 
length of 960 amino acids and are presumably sufficiently stable to 
p ersist u1tracellularly for some time, prior to degradation through 
default pathways. This is a likely explanation for the positive signal 
with the LH-7.2 antibody, because the epitope recognized by this 
antibody is located u1 the nuddle of the NC-1 domain (Tanaka eta/, 
1994), a region that is u1cluded in the truncated polypeptide. The 
truncated chau1s, however, may not be sufficiently stable to persist 
during the extraction procedures for immunoblotting. 
The ultrastructural demonstration of small amounts of very short 
hypoplastic fibril-like structures inserting u1to the basal lamina, but 
la ck of normal anchotmg fibrils, could correspond with tl1e syn-
thesis of truncated polypeptide chains containing the NC- 1 domain 
that may be secreted and incorporated in 11il'o and persi st as 
rudimentary chains for some time, whereas no functional chaiJlS of 
normal length are synthesized. It is not possible, however, to 
defiJlitively distinguish these structures from other fibrillar aggre-
gates of the pathologically altered sublamiJ1a deusa zone of EBD 
skin. 
The maternal mutation 425-A ---'> G found in the present EBD 
family seems to be a more common mutation than usually observed 
in EBD. It was first described by Ch.-istiano c/ a/ (1994) as an 
intrageni c polymorphism of COL7 A1, with an allelic frequency of 
14% among 36 chromosomes. Recently, Gardella el nl (1996) 
reported the same sequence variation in an Italian proband with 
localized EBD and in Ius futher and showed that it led to abnormal 
spli cu1g of the mR.NA with the consequence ofPTCs. Because we 
identified the same sequence variation in a German EBD child and 
Ius mother, it can be considered as a mutation causu1g a recessive 
disease, with a fi·equency higher than most COL7 A1 mutations. 
Interestingly, it was not found in 200 chromosomes of wu-elated 
unaffected Italian and in 150 chromosomes of unrelated unaffected 
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German individuals. In addition, three Italian and 19 Central 
European EBD f:m1ilies did not have this mutation . The reason for 
the discrepancy is not clear, it could be due to different control 
populations , different ethnic backgrounds, o r the number of indi-
viduals tested. 
When comparing the phenotypes of the present proband and the 
patient described by Gardella et a/ (1996), both of them harboring 
the 425-A -> G mutati on in one allele, it seems th at the severity of 
the phenotype is determined by the mutation in the other allele. 
The proband described by Gardella e/ a/ (1996) showed a m ild 
phenotype, and in addition to the 425-A ----7 G, had also a spl icing 
mutation in the other allele within intron 95. The latter mutation 
resu lted, in addition to aberrant spli cing, also in correctly spliced 
ml~A with the consequence that some normal colla gen Vil was 
syn thesized . ln contras t, in the presen t case w ith severe recessive 
EBD phenotype, markedly redu ced amounts of truncated polypep-
tides were synth esized, and no intact coll agen V II was secreted. In 
this context it should be ernphasized, however, that in spite of a 
remarkable number of different mutations revea led in the COL7 Al 
gene (for reviews, see C hristiano and Uitto, 1996a, 1996b ), it is not 
yet possible to predict the clinica l phenotype o r the course of th e 
disease fimn the type of mutation. 
Although only a limited number of compound heterozygous 
COL7A1 gene mutations have been described thus far , it is evident 
how extensive the molecular heterogene ity of EBD may be. 
Various combinations of two mutations leading to different conse-
quences fm· the multimeric collagen VII aggregates can account for 
a vast variety of biologic and clinical phenotypes. Underst~nding 
the molecular events leading to different phenotypes is essen tial, 
beca use it forms an indi spensable basis for genetic counseling and 
des ign of nove l therapeutic strategies for these devastating diseases . 
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